An article by MJN

Unlike the bracelet-shaped devices available on the market, MJN-SERAS records the electrical activity of the brain through the ear canal. In combination with a mobile application containing artificial intelligence algorithms, MJN-SERAS works by calculating continuously the risk of having an epileptic seizure.

In this way, when MJN-SERAS detects that the risk of seizures is very high, it warns the person and his/her environment in order to take all preventive measures and avoid the risk of having an accident as a result of the crisis.

How did we manage to advance to the crisis?

MJN-SERAS is designed for each person. Firstly, the sensor that is placed in the ear canal is made by printing 3d tailored to each person. In Spain, in order to achieve this personalization, we have an agreement with GAES Hearing Centers. All our users can go to their nearest GAES centre to make an ear mould . Thus, the sensor of the receiver is manufactured with the perfect size so that is comfortable during many hours of use .

We teach artificial intelligence algorithm how the seizures of each user are

And now comes the more complex part. Each person has a unique epileptic seizure. And although they can be classified by type, they are finally personal. At MJN, teaches each user’s artificial intelligence algorithm how their seizures are. This way we can train it so that its reliability is higher.

How do we teach each algorithm?

When you receive your MJN-SERAS unit, you can start using it immediately. As we record and store your activity in a health folder, we can record when epileptic seizures occur. When the user marks us between 3 and 5 seizures, we teach the artificial intelligence algorithm to identify “those” seizures on MJN mainframe computers. When the algorithm is taught, is installed in the person’s mobile to work exclusively for him..

MJN-SERAS has been designed with the unique objective of improving the quality of life of people with epilepsy and has been devised by people who know first hand which means not knowing when the next seizure will occur . In fact, one of the founders of MJN, has a daughter with drug-resistant epilepsy for more than 15 years .

MJN-SERAS
Find out your risk of having an epileptic seizure at any time and place.

Leave a Reply

L’usuari que complimenta la informació requerida al present formulari declara estar legitimat per això i es fa responsable exclusiu de la veracitat i integritat de les dades i informació que introdueix, exonerant expressament a MJN NEUROSERVEIS de qualsevol responsabilitat que es pugi generar per aquesta entitat amb ocasió de la informació facilitat a través del present formulari.

Si, accepto

El usuario que cumplimenta la información requerida en el presente formulario declara estar legitimado para ello y se hace responsable exclusivo de la veracidad e integridad de los datos e información que introduce, exonerando expresamente a MJN NEUROSERVEIS de cualquier responsabilidad que pudiera generarse para esta entidad con ocasión de la información facilitada a través del presente formulario.

Sí, acepto

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!


    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.
    CPSP20103CAT.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.

    ¡Inscríbete!

      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.
      CPSP20103CAT.